Atossa Genetics announced that all participant activities have been completed in its Phase 1 clinical trial of a new proprietary modified-release
oral tablet form of its Endoxifen.
Mayne Pharma has two product development and manufacturing facilities based in Salisbury, Australia and Greenville, USA with expertise in formulation of complex oral and topical dose forms including potent compounds, modified-release
products and inherently unstable compounds.
Technology & Role of Physico-Chemical Properties of Polymers in Hot Melt Extrusion
WEDNESDAY, June 26, 2019 (HealthDay News) -- Combining ivermectin cream (IVM) and doxycycline modified-release
capsules (DMR) can improve response rates for patients with severe rosacea, according to a study recently published in the Journal of the American Academy of Dermatology.
melatonin recommended by sleep specialists in the United States.
FDA issued a final guidance, "Opioid Use Disorder: Developing Buprenorphine Depot Products for Treatment," which outlines the FDA's current thinking about drug development and trial design issues relevant to the study of buprenorphine depot products, such as modified-release
products for injection or implantation.
Quotient has comprehensive drug product expertise spanning all dosage forms, from liquids to solids, immediate-release to modified-release
, and solubilisation technologies including spray-dried dispersions, micronized and lipidic formulations.
Last month, the FDA issued draft guidance outlining new ways for drug developers to consider measuring and demonstrating the effectiveness and benefits of new or existing MAT products, building on another draft guidance issued in April outlining the agency's current thinking about drug development and trial design issues relevant to the study of depot buprenorphine products (i.e., modified-release
products for injection or implantation).
It also introduces significant capacity to manufacture potent compounds and new capability to manufacture modified-release
Ross, "An oral multiparticulate, modified-release
, hydrocortisone replacement therapy that provides physiological cortisol exposure," Clinical Endocrinology, vol.
Efficacy of modified-release
versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomized controlled trial.